Volume: 43 Issue: 2
Year: 2023, Page: 554-558, Doi: https://doi.org/10.51248/.v43i02.2628
The effectiveness of the anti-tubercular treatment (ATT) depends on adherence to the proposed highly effective therapeutic scheme. When the patient starts ATT and fails to come to the healthcare facility for more than 30 consecutive days from the date scheduled for his return, it is considered abandonment. The objective was to identify the difficulties associated with non-adherence and abandonment of the ATT regimen and evaluate the regulation of anti-tuberculosis drugs in Kyrgyzstan. Patients with tuberculosis make the decision to abandon treatment because they are unaware of the time needed, the continuity of treatment, and for reasons of the disappearance of signs and symptoms. The use of alcohol and illicit drugs has a poor prognosis for the treatment, factors that predispose patients to abandon the treatment and prolong the drug therapy. The majority of the patients discontinue treatment because of adverse effects, contributing to the interruption of treatment, so patients should be assisted regularly. To strengthen the requirements for the quality of purchased anti-tuberculosis drugs, when drawing up the technical specification of the government decree of Kyrgyzstan, it is necessary to give preference to drugs that have been prequalified by World Health Organization or evaluated by strict regulatory authorities
Keywords: Tuberculosis; anti-tubercular treatment; anti-tubercular drugs; non-adherence; adverse effects.
1. Abdu, M., Ali, Y., Anteneh, S., Yesuf, M., Birhanu, A., Mohamed, S., et al. Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study. PLoS One. 2021;16(3): e0248490.
2. Ruru, Y., Matasik, M., Oktavian, A., Senyorita, R., Mirino, Y., Tarigan, L. H., et al. Factors associated with non-adherence during tuberculosis treatment among patients treated with DOTS strategy in Jayapura, Papua Province, Indonesia. Glob Health Action. 2018;11(1):1510592.
3. Guidelines for Treatment of Tuberculosis (4th edition). World Health Organization, 2010. Available from: www.who.int/tb/ publications/2010/9789241547833/en/. Last accessed on 16 January 2023.
4. Bea, S., Lee, H., Kim, J. H., Jang, S. H., Son, H., Kwon, J. W., et al. Adherence and associated factors of treatment regimen in drug-susceptible tuberculosis patients. Front Pharmacol. 2021; 12:625078.
5. Oliveira, S. A. G., Lima, C. A., Quirino, B. E. M., Andrade, R. M. L., Lima, A. A., Silva, M. A. S., et al. Adhesion and quality of life in patients with pulmonary tuberculosis. Rev Enferm UFPE Online. 2019; 13(3):697-706.
6. Sá, A. M. M., Laryssa, A. S., Natasha, V. S., Nina, P. M., Paulinne, H. A. P., Anita, M. L., et al. Reasons for treatment abandonment among tuberculosis patients. Rev Soc Bras Clin Med. 2017;15(3):155-160.
7. Zumla, A. I., Gillespie, S. H., Hoelscher, M., Philips, P. P., Cole, S. T., Abubakar, I., et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis. 2014; 14(4):327-340.
8. Ginsberg A. M. Tuberculosis drug development: progress, challenges, and the road ahead. Tuberculosis (Edinb). 2010; 90(3):162-167.
9. Ma, Z., Lienhardt, C., McIlleron, H., Nunn, A. J., Wang, X. Global tuberculosis drug development pipeline: the need and the reality. Lancet. 2010; 375(9731):2100-2109.
10. Costa, J. S. D., Gonclves, H., Menezes, A. M. B., Devens, E., Piva, M., Gomes, M., et al. Epidemiological control of tuberculosis in pelotas, rio grande do sul, Brazil: treatment compliance. Cad Saude Publica. 1998;14(2):409-415.
11. Chirinos, N. E., Meirelles, B. H., Bousfield, A. B. Social representations of TB patients on treatment discontinuation. Rev Gaucha Enferm. 2015;36 Spec No:207-214.
12. Beraldo, A. A., Andrade, R. L. P., Orfão, N. H., Silva-Sobrinho, R, A., Pinto, E. S. G., Wysocki, A. D., et al. Adherence to tuberculosis treatment in Primary Health Care: perception of patients and professionals in a large municipality. Esc Anna Nery. 2017;21(4):1-8.
13. Calsin, C. N. E., Meirelles, H. S. B., Bousfield B. S. A., Santos, F. G. Social representations of tuberculosis treatment abandonment: study of health professionals. Cuid salud. 2015;2(1):117-124.
14. Tesfahuneygn, G., Medhin, G., Legesse, M. Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC Res Notes. 2015; 8:503.
15. Sousa, G. J. B., Maranhão, T. A., Leitão, T. D. M. J. S., Souza, J. T., Moreira, T. M. M., Pereira, M. L. D. Prevalence and associated factors of tuberculosis treatment abandonment. Rev Esc Enferm USP. 2021; 55:e03767.
16. Law of the Kyrgyz Republic "On Public Procurement" dated April 03, 2015 No. 72. Available from: https://www.pplo.kg/ en/repository/25/. Last accessed on 16 January 2023.
17. Order of the Ministry of Finance of the Kyrgyz Republic “About approval of regulatory legal acts in the sphere of public procurements” dated October 14, 2015 No. 175-p. Available from: https://cis-legislation.com/document. fwx?rgn=80735. Last accessed on 16 January 2023.
18. Official Public Procurement Portal. Ministry of Finance of the Kyrgyz Republic. Available from: http://zakupki.gov.kg/ popp/home.xhtml, Last accessed on 16 January 2023.
19. Law of the Kyrgyz Republic "On Circulation of medicines" No. 165 dated August 02, 2017. Available from: https://www.kgma.kg/pdf/appendix-6-sfc-gia.pdf. Last accessed on 16 January 2023.
20. Order of Government of the Kyrgyz Republic "About approval of the Procedure for evaluating quality of medicines" dated July 05, 2018 No. 312. Available from: https://cis-legislation.com/document.fwx?rgn=140904. Last accessed on 16 January 2023
Nargiza Toktonalieva, Iskhak Toktonaliev, Saltanat Kadyrkulova. Identification of factors associated with non-adherence and discontinuation of antitubercular drugs in patients with tuberculosis. Biomedicine: 2023; 43(2): 554-558